C150H322N24O7 — CID 161405066
N-tert-butylcyclohexanamine;bis(N-tert-butyl-1-methylpiperidin-4-amine);N-(cyclohexylmethyl)-2-methylpropan-2-amine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);bis(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine;1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethanone;N-(2-piperidin-1-ylethyl)propan-2-amine (PubChem CID 161405066) has the molecular formula C150H322N24O7 and a molecular weight of 2574.39 g/mol. Its IUPAC name is N-tert-butylcyclohexanamine;bis(N-tert-butyl-1-methylpiperidin-4-amine);N-(cyclohexylmethyl)-2-methylpropan-2-amine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);bis(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine;1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethanone;N-(2-piperidin-1-ylethyl)propan-2-amine.
| Compound Name | N-tert-butylcyclohexanamine;bis(N-tert-butyl-1-methylpiperidin-4-amine);N-(cyclohexylmethyl)-2-methylpropan-2-amine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);bis(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine;1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethanone;N-(2-piperidin-1-ylethyl)propan-2-amine |
|---|---|
| PubChem CID | 161405066 |
| Molecular Formula | C150H322N24O7 |
| Molecular Weight | 2574.39 g/mol |
| Exact Mass | 2572.56 |
| IUPAC Name | N-tert-butylcyclohexanamine;bis(N-tert-butyl-1-methylpiperidin-4-amine);N-(cyclohexylmethyl)-2-methylpropan-2-amine;bis(1-(3,3-dimethylbutyl)-4-methylpiperazine);bis(2-methyl-N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine);bis(1-methyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine);1-methyl-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;4-[2-[(2-methylpropan-2-yl)oxy]ethyl]morpholine;1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethanone;N-(2-piperidin-1-ylethyl)propan-2-amine |
| SMILES | CC(=O)N1CCN(CCOC(C)(C)C)CC1.CC(C)(C)NC1CCCCC1.CC(C)(C)NCC1CCCCC1.CC(C)(C)OCCN1CCOCC1.CC(C)NCCN1CCCCC1.CN1CCC(CNC(C)(C)C)CC1.CN1CCC(CNC(C)(C)C)CC1.CN1CCC(COC(C)(C)C)CC1.CN1CCC(NC(C)(C)C)CC1.CN1CCC(NC(C)(C)C)CC1.CN1CCN(CCC(C)(C)C)CC1.CN1CCN(CCC(C)(C)C)CC1.CN1CCN(CCOC(C)(C)C)CC1.CN1CCN(CCOC(C)(C)C)CC1 |
| InChI | InChI=1S/C12H24N2O2.2C11H24N2O.4C11H24N2.C11H23NO.C11H23N.3C10H22N2.C10H21NO2.C10H21N/c1-11(15)14-7-5-13(6-8-14)9-10-16-12(2,3)4;2*1-11(2,3)14-10-9-13-7-5-12(4)6-8-13;2*1-11(2,3)12-9-10-5-7-13(4)8-6-10;2*1-11(2,3)5-6-13-9-7-12(4)8-10-13;1-11(2,3)13-9-10-5-7-12(4)8-6-10;1-11(2,3)12-9-10-7-5-4-6-8-10;2*1-10(2,3)11-9-5-7-12(4)8-6-9;1-10(2)11-6-9-12-7-4-3-5-8-12;1-10(2,3)13-9-6-11-4-7-12-8-5-11;1-10(2,3)11-9-7-5-4-6-8-9/h5-10H2,1-4H3;2*5-10H2,1-4H3;2*10,12H,5-9H2,1-4H3;2*5-10H2,1-4H3;10H,5-9H2,1-4H3;10,12H,4-9H2,1-3H3;2*9,11H,5-8H2,1-4H3;10-11H,3-9H2,1-2H3;4-9H2,1-3H3;9,11H,4-8H2,1-3H3 |
| InChIKey | VUSQYGZOZUPMAL-UHFFFAOYSA-N |
| XLogP | 23.18 |
| TPSA | 211.74 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 31 |
| Heavy Atoms | 181 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2574.39 |
| LogP ≤ 5 | 23.18 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 30 |